Irina Babina

CEO at Concr

Presenter

Trained as a geneticist, Irina spent over 12 years as a cancer scientist, developing targeted breast and gastric cancer therapies and researching mechanisms of cancer resistance at the Royal College of Surgeons and the Institute of Cancer Research in London. Seeing lack of translation of promising science, she turned to funding management and investing, helping other researchers with the development of their healthcare innovations, deploying over £120m+ of public and VC funds into innovation. This led her to Concr - a deeptech company that applies astrophysics-derived Bayesian computational methods to create "digital twins" of patient biology. This technology enables precise predictions of therapeutic responses, equipping oncologists and pharmaceutical companies to optimise clinical trials and improve patient outcomes. After holding several leadership roles, she was appointed CEO in 2024.